Clinical Trials Logo

Clinical Trial Details — Status: Recruiting

Administrative data

NCT number NCT04828785
Other study ID # 20-2847
Secondary ID R01DK125831
Status Recruiting
Phase N/A
First received
Last updated
Start date July 2, 2021
Est. completion date January 2026

Study information

Verified date June 2024
Source University of North Carolina, Chapel Hill
Contact Katharine Ricks, PhD
Phone 919-843-6637
Email kathier1@email.unc.edu
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

The investigators propose a single-site, open-label, Phase II, community-based randomized clinical explanatory trial to test the efficacy of a medically tailored meal (MTM) interventions for adults with food insecurity and T2DM (Type 2 Diabetes Mellitus). While the efficacy of MTM needs to be established, given the nature of the population served by MTM, it is important to design the study to enhance the external validity/generalizability of the findings as much as possible. The investigators will recruit 200 participants from the referral list of Community Servings, a Boston-based MTM provider, and randomly assign them to MTM (N=100) or usual care + monthly food subsidy (N=100). MTM intervention will consist of 6 months of weekly delivery of 10 ready-to-eat meals (approximately half an individual's weekly food intake), along with telephone-based lifestyle intervention that prepares participants for the post-treatment period. The usual care + food subsidy recipients will receive usual care along with 6 months of a $40/month food subsidy.


Description:

Food insecurity, "lack of access to enough food for an active, healthy life", affects over 20% of the 30 million Americans with diabetes. Food insecurity is more common in racial/ethnic minorities and those with lower socioeconomic status. Moreover, food insecurity is associated with worse diabetes control and increased complications, even after adjusting for other risk factors. Food insecurity is a major contributor to disparities in diabetes outcomes. Medically tailored meal (MTM) delivery programs are a promising intervention for individuals with diabetes and food insecurity. MTM programs deliver fully prepared food, tailored by a registered dietitian nutritionist to the specific medical needs of the individual, and provide education to help optimize disease self-management. Food insecurity is typically addressed with food subsidies-offering additional financial resources that can be spent on food. While both food subsidies and MTM can increase healthy food access, MTM can help overcome other barriers to diabetes management including lack of time, ability, knowledge, and skills needed to prepare appropriate meals. The use of these programs is often called 'food as medicine', as the purpose is to provide exactly the foods needed to help prevent diabetes complications. MTM are receiving increasing public attention, but there are, as of yet, no full-scale trials to test its effects on diabetes outcomes when compared with other food insecurity interventions. Our research team has developed a medically tailored meal intervention that combines provision of healthy food, tailored to the specific nutrition needs of the individual, with an evidence-based lifestyle intervention that uses the period of meal delivery as springboard to improve diabetes self-management, both while receiving meals and after meal delivery is completed. This study is an explanatory-focused randomized trial to assess a community-based medically tailored meals intervention (n=200). It will be conducted among diverse participants referred for medically tailored meals. Adults with type 2 diabetes, Hemoglobin A1c between 7.0% and 12.0%, and BMI ≥ 25 kg/m2 (≥ 23 kg/m2 for those with Asian ancestry) will be enrolled and randomly assigned to intervention or usual care + food subsidy. The intervention group will receive meal delivery and its attendant lifestyle intervention for 6 months, while the usual care + food subsidy group will receive a $40/month food subsidy, along with usual diabetes care.


Recruitment information / eligibility

Status Recruiting
Enrollment 200
Est. completion date January 2026
Est. primary completion date August 2025
Accepts healthy volunteers No
Gender All
Age group 18 Years and older
Eligibility Inclusion Criteria: - Diagnosis of Type 2 Diabetes Mellitus - Hemoglobin A1c = 7.0% and = 12.0% in last 12 months - Experiencing food insecurity as indicated by 2-item Hunger Vital Sign - English speaking - BMI =25 kg/m^2 (= 23 kg/m^2 if self-report Asian ancestry) - No plans to move from the area for at least 1 year - Free living to the extent that participant has control over dietary intake - Willing and able to provide written informed consent and participate in all study activities Exclusion Criteria: - Participant in diabetes, nutrition, or weight research intervention in last 12 months - Another family member or household member is a study participant. Only one member of each household may take part in this study. - Considering bariatric surgery in the next year or prior bariatric surgery in the past 2 years - Lack of safe, stable residence and ability to store meals - Lack of telephone - Pregnancy/breastfeeding or intended pregnancy in the next year - History of malignancy, other than non-melanoma skin cancer, unless surgically or medically cured > 5 years ago or in remission. Patients with localized prostate and breast cancer diagnosed during the course of routine screening will not be excluded. - Advanced kidney disease (estimated creatinine clearance < 30 mL/min) - Known drug or alcohol misuse in the past 2 years - Known psychosis or major psychiatric illness that prevents participation with study activities - Intermittent use of medications (e.g., oral or intravenous glucocorticoids) that are likely to affect blood sugar

Study Design


Related Conditions & MeSH terms


Intervention

Other:
MTM
weekly home meal delivery; an explanation of the medical tailoring of the meals; and a 6-session telephone lifestyle intervention change program designed to complement the period of meal delivery and prepare for the period after meal delivery with behavioral and skill-building approaches to sustain the benefit of the intervention.
Food Subsidy
$40/month food subsidy

Locations

Country Name City State
United States University of North Carolina at Chapel Hill Chapel Hill North Carolina

Sponsors (4)

Lead Sponsor Collaborator
University of North Carolina, Chapel Hill Community Servings, Massachusetts General Hospital, National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)

Country where clinical trial is conducted

United States, 

Outcome

Type Measure Description Time frame Safety issue
Other Bodyweight at Month 6 Bodyweight measured in Kg 6 months
Other Bodyweight at Month 12 Bodyweight measured in Kg 12 months
Other Systolic Blood Pressure at Month 6 Systolic blood pressure in mm Hg 6 months
Other Systolic Blood Pressure at Month 12 Systolic blood pressure in mm Hg 12 months
Other Diastolic Blood Pressure at Month 6 Diastolic blood pressure measured in mm Hg 6 months
Other Diastolic Blood Pressure at Month 12 Diastolic blood pressure in mm Hg 12 months
Other Diet Quality Score at Month 6 Diet Quality as assessed by Brief Dietary Assessment Scale. This score is comprised of 3 sections (or subscales) used to assess dietary patterns. Subscales are scored independently. The subscales are: Vegetables, Fruit, Whole Grains, and Beans subscale (range 0 - 20), Drinks, Desserts, Snacks, Eating Out, and Salt subscale (range 0- 20), and Fish, Meat, Poultry, Dairy, and Eggs subscale (range 0-10): Total score equals the sum of the 3 subscales. For subscales and total score, higher scores indicates better diet quality. 6 months
Other Diet Quality Score at Month 12 Diet Quality as assessed by Brief Dietary Assessment Scale. This score is comprised of 3 sections (or subscales) used to assess dietary patterns. Subscales are scored independently. The subscales are: Vegetables, Fruit, Whole Grains, and Beans subscale (range 0 - 20), Drinks, Desserts, Snacks, Eating Out, and Salt subscale (range 0- 20), and Fish, Meat, Poultry, Dairy, and Eggs subscale (range 0-10): Total score equals the sum of the 3 subscales. For subscales and total score, higher scores indicates better diet quality. 12 months
Other Cost-Related Medication Underuse at Month 6 Any affirmative response to cost-related medication underuse items 6 months
Other Cost-Related Medication Underuse at Month 12 Any affirmative response to cost-related medication underuse items 12 months
Other ARMS-D (Adherence to Refills and Medications Scale-Diabetes) Medication Adherence Score at Month 6 Medication Adherence as assessed by 7-item ARMS-D scale. Scores range from 7 to 28, with higher scores indicating more problems with adherence. 6 months
Other ARMS-D Medication Adherence Score at Month 12 Medication Adherence as assessed by 7-item ARMS-D scale. Scores range from 7 to 28, with higher scores indicating more problems with adherence. 12 months
Other Diabetes Self-Care Activities Medication Adherence Score at Month 6 Medication Adherence as assessed by 1-item summary of diabetes self-care activities measure. Scores range from 0-7 with higher scores indicating better adherence. 6 months
Other Diabetes Self-Care Activities Medication Adherence Score at Month 12 Medication Adherence as assessed by 1-item summary of diabetes self-care activities measure. Scores range from 0-7 with higher scores indicating better adherence. 12 months
Other Food/Medication Trade-offs at Month 6 Single item-indicators of trading off medication for food or food for medication. An affirmative response indicates the presence of a trade-off. 6 months
Other Food/Medication Trade-offs at Month 12 Single item-indicators of trading off medication for food or food for medication. An affirmative response indicates the presence of a trade-off. 12 months
Other Housing Insecurity at Month 6 Self-report of being worried about losing housing 6 months
Other Housing Insecurity Score at Month 12 Self-report of being worried about losing housing 12 months
Other Transportation Barriers at Month 6 Self-report of transportation barriers to attending medical appointments 6 months
Other Transportation Barriers at Month 12 Self-report of transportation barriers to attending medical appointments 12 months
Other Financial Strain Self-report of financial strain 6 months
Other Financial Strain Self-report of financial strain 12 months
Other Care Delay at Month 6 Self-report of delaying healthcare due to cost 6 months
Other Care Delay at Month 12 Self-report of delaying healthcare due to cost 12 months
Other Diet Self-Efficacy Score at Month 6 Diet Self-Efficacy as assessed by cardiac diet self-efficacy scale. Scores range from 16 to 80 with higher scores indicating greater self-efficacy. 6 months
Other Diet Self-Efficacy Score at Month 12 Diet Self-Efficacy as assessed by cardiac diet self-efficacy scale. Scores range from 16 to 80 with higher scores indicating greater self-efficacy. 12 months
Other Perceived Diabetes Self-Management Self-Efficacy Score at Month 6 Diabetes Self-Efficacy as assessed by Perceived Diabetes Self-Management Scale. Scores range from 8 to 40 with higher scores indicating greater self-efficacy 6 months
Other Perceived Diabetes Self-Management Self-Efficacy Score at Month 12 Diabetes Self-Efficacy as assessed by Perceived Diabetes Self-Management Scale. Scores range from 8 to 40 with higher scores indicating greater self-efficacy 12 months
Other Stress Score at 6 months Stress as assessed by perceived stress scale. Scores range from 0 to 40 with higher scores indicating higher perceived stress. 6 months
Other Stress Score at 12 months Stress as assessed by perceived stress scale. Scores range from 0 to 40 with higher scores indicating higher perceived stress. 12 months
Primary Hemoglobin A1c at Month 6 Hemoglobin A1c Level 6 months
Secondary Hemoglobin A1c at Month 12 Hemoglobin A1c Level 12 months
Secondary Food Insecurity Score at Month 6 Food Insecurity Score. Score ranges from 0-10, with higher scores indicating greater food insecurity. 6 months
Secondary Food Insecurity Score at Month 12 Food Insecurity Score. Score ranges from 0-10, with higher scores indicating greater food insecurity. 12 months
Secondary Health-Related Quality of Life Score as assessed by PROMIS (Patient-Reported Outcomes Measurement Information System)-29 at Month 6 The PROMIS-29 includes seven health related quality of life domains (Physical Functioning, Anxiety, Depression, Fatigue, Sleep Disturbance, Social Functioning, and Pain), and the pain domain has two subdomains (interference and intensity). Raw scores, except pain intensity, are transformed using the T-score metric based on the item response theory calibrations in which scores have a mean of 50 and standard deviation of 10 for the general population in the US. A higher PROMIS T-score implies more of the concept being measured; i.e., a higher PROMIS score on physical function indicates better functioning, whereas a higher score on depression indicates more severe depressive symptoms. Will report overall score and scores for each domain. From these data we will also calculate a PROMIS-Preference (PROPr score) (PROPr scores range from -0.022 (worst) to 1.0 (best)). 6 months
Secondary Health-Related Quality of Life Score as assessed by PROMIS-29 at Month 12 The PROMIS-29 includes seven health related quality of life domains (Physical Functioning, Anxiety, Depression, Fatigue, Sleep Disturbance, Social Functioning, and Pain), and the pain domain has two subdomains (interference and intensity). Raw scores, except pain intensity, are transformed using the T-score metric based on the item response theory calibrations in which scores have a mean of 50 and standard deviation of 10 for the general population in the US. A higher PROMIS T-score implies more of the concept being measured; i.e., a higher PROMIS score on physical function indicates better functioning, whereas a higher score on depression indicates more severe depressive symptoms. Will report overall score and scores for each domain. From these data we will also calculate a PROMIS-Preference (PROPr score) (PROPr scores range from -0.022 (worst) to 1.0 (best)). 12 months
Secondary Diabetes Distress Score as assessed by PAID (Problem Areas in Diabetes)-11 at Month 6 Score ranges from 11-55 with higher scores indicating greater diabetes distress 6 months
Secondary Diabetes Distress Score as assessed by PAID-11 at Month 12 Score ranges from 11-55 with higher scores indicating greater diabetes distress 12 months
Secondary Depressive Symptom Score at Month 6 Depressive Symptoms as assessed by PROMIS SF (Short Form) v1.0 - Depression 4a. Raw scores are transformed using the T-score metric based on the item response theory calibrations in which scores have a mean of 50 and standard deviation of 10 for the general population in the US. A higher PROMIS T-score implies more of the concept being measured; i.e., a higher PROMIS score on depression indicates more severe depressive symptoms. 6 months
Secondary Depressive Symptom Score at Month 12 Depressive Symptoms as assessed by PROMIS SF v1.0 - Depression 4a. Raw scores are transformed using the T-score metric based on the item response theory calibrations in which scores have a mean of 50 and standard deviation of 10 for the general population in the US. A higher PROMIS T-score implies more of the concept being measured; i.e., a higher PROMIS score on depression indicates more severe depressive symptoms. 12 months
Secondary Frequency of self-reported hypoglycemia at Month 6 Categorized by number of episodes on prior 3 months 6 months
Secondary Frequency of self-reported hypoglycemia at Month 12 Categorized by number of episodes on prior 3 months 12 months
Secondary Frequency of self-reported severe hypoglycemia at Month 6 Categorized by number of episodes on prior 3 months 6 months
Secondary Frequency of self-reported severe hypoglycemia at Month 12 Categorized by number of episodes on prior 3 months 12 months
See also
  Status Clinical Trial Phase
Active, not recruiting NCT05666479 - CGM Monitoring in T2DM Patients Undergoing Orthopaedic Replacement Surgery
Completed NCT05647083 - The Effect of Massage on Diabetic Parameters N/A
Active, not recruiting NCT05661799 - Persistence of Physical Activity in People With Type 2 Diabetes Over Time. N/A
Completed NCT03686722 - Effect of Co-administration of Metformin and Daclatasvir on the Pharmacokinetis and Pharmacodynamics of Metformin Phase 1
Completed NCT02836704 - Comparison of Standard vs Higher Starting Dose of Insulin Glargine in Chinese Patients With Type 2 Diabetes (Glargine Starting Dose) Phase 4
Completed NCT01819129 - Efficacy and Safety of FIAsp Compared to Insulin Aspart in Combination With Insulin Glargine and Metformin in Adults With Type 2 Diabetes Phase 3
Completed NCT04562714 - Impact of Flash Glucose Monitoring in People With Type 2 Diabetes Using Non-Insulin Antihyperglycemic Therapy N/A
Completed NCT02009488 - Treatment Differences Between Canagliflozin and Placebo in Insulin Secretion in Subjects With Type 2 Diabetes Mellitus (T2DM) Phase 1
Completed NCT05896319 - Hyaluronic Acid Treatment of the Post-extraction Tooth Socket Healing in Subjects With Diabetes Mellitus Type 2 N/A
Recruiting NCT05598203 - Effect of Nutrition Education Groups in the Treatment of Patients With Type 2 Diabetes N/A
Completed NCT05046873 - A Research Study Looking Into Blood Levels of Semaglutide and NNC0480-0389 When Given in the Same Injection or in Two Separate Injections in Healthy People Phase 1
Completed NCT04030091 - Pulsatile Insulin Infusion Therapy in Patients With Type 1 and Type 2 Diabetes Mellitus Phase 4
Terminated NCT04090242 - Impact of App Based Diabetes Training Program in Conjunction With the BD Nano Pen Needle in People With T2 Diabetes N/A
Completed NCT03604224 - A Study to Observe Clinical Effectiveness of Canagliflozin 300 mg Containing Treatment Regimens in Indian Type 2 Diabetes Participants With BMI>25 kg/m^2, in Real World Clinical Setting
Completed NCT03620357 - Continuous Glucose Monitoring & Management In Type 2 Diabetes (T2D) N/A
Completed NCT01696266 - An International Survey on Hypoglycaemia Among Insulin-treated Patients With Diabetes
Completed NCT03620890 - Detemir Versus NPH for Type 2 Diabetes Mellitus in Pregnancy Phase 4
Withdrawn NCT05473286 - A Research Study Looking at How Oral Semaglutide Works in People With Type 2 Diabetes in Germany, as Part of Local Clinical Practice
Not yet recruiting NCT05029804 - Effect of Walking Exercise Training on Adherence to Disease Management and Metabolic Control in Diabetes N/A
Completed NCT04531631 - Effects of Dorzagliatin on 1st Phase Insulin and Beta-cell Glucose Sensitivity in T2D and Monogenic Diabetes Phase 2